Experimental models of multiple sclerosis

被引:63
|
作者
Pachner, Andrew R. [1 ]
机构
[1] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Neurol & Neurosci, Newark, NJ 07103 USA
关键词
animal models; autoimmunity; demyelination; multiple sclerosis; virus; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CENTRAL-NERVOUS-SYSTEM; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; THEILERS-VIRUS-INFECTION; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; B-CELL DEPLETION; DEMYELINATING DISEASE; NEUROMYELITIS-OPTICA; VIRAL REPLICATION; IMMUNE-RESPONSES;
D O I
10.1097/WCO.0b013e328346c226
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Purpose of review Multiple sclerosis (MS) is a disease of the central nervous system of unknown cause. There are many medications available for the disease, but none are clearly effective in ameliorating its long-term disabling effects. MS is felt to be most likely either due to an aberrant immune response or a pathogen, or possibly a combination of the two, and the animal models available reflect these two possible pathogeneses. The hallmarks of the disease are demyelination, inflammation, axonal injury, and progressive disability. This review explores the experimental models of multiple sclerosis. Recent findings There are a variety of forms of experimental allergic encephalomyelitis, the most commonly studied animal model of MS. Two viruses, Theiler's murine encephalomyelitis virus and murine hepatitis virus, are used to induce infectious models of the disease. Summary The animal models have their advantages and disadvantages, but no model fully reproduces the spectrum of the human disease.
引用
收藏
页码:291 / 299
页数:9
相关论文
共 50 条
  • [41] The contribution of astrocytes to the neuroinflammatory response in multiple sclerosis and experimental autoimmune encephalomyelitis
    Brambilla, Roberta
    ACTA NEUROPATHOLOGICA, 2019, 137 (05) : 757 - 783
  • [42] Toll-like Receptors in Multiple Sclerosis Mouse Experimental Models
    Marta, Monica
    CONTEMPORARY CHALLENGES IN AUTOIMMUNITY, 2009, 1173 : 458 - 462
  • [43] Lesion Expansion in Experimental Demyelination Animal Models and Multiple Sclerosis Lesions
    Grosse-Veldmann, Rene
    Becker, Birte
    Amor, Sandra
    van der Valk, Paul
    Beyer, Cordian
    Kipp, Markus
    MOLECULAR NEUROBIOLOGY, 2016, 53 (07) : 4905 - 4917
  • [44] Transcriptomic Meta-Analysis of Multiple Sclerosis and Its Experimental Models
    Raddatz, Barbara B. R.
    Hansmann, Florian
    Spitzbarth, Ingo
    Kalkuhl, Arno
    Deschl, Ulrich
    Baumgaertner, Wolfgang
    Ulrich, Reiner
    PLOS ONE, 2014, 9 (01):
  • [45] EAE: imperfect but useful models of multiple sclerosis
    't Hart, Bert A.
    Gran, Bruno
    Weissert, Robert
    TRENDS IN MOLECULAR MEDICINE, 2011, 17 (03) : 119 - 125
  • [46] Experimental Models of Autoimmune Demyelinating Diseases in Nonhuman Primates
    Stimmer, Lev
    Fovet, Claire-Maelle
    Serguera, Che
    VETERINARY PATHOLOGY, 2018, 55 (01) : 27 - 41
  • [47] The role of myelin oligodendrocyte glycoprotein in autoimmune demyelination: a target for multiple sclerosis therapy?
    Lee, De-Hyung
    Linker, Ralf A.
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2012, 16 (05) : 451 - 462
  • [48] Studies in Experimental Autoimmune Encephalomyelitis Do Not Support Developmental Bisphenol A Exposure as an Environmental Factor in Increasing Multiple Sclerosis Risk
    Krementsov, Dimitry N.
    Katchy, Anne
    Case, Laure K.
    Carr, Frances E.
    Davis, Barbara
    Williams, Cecilia
    Teuscher, Cory
    TOXICOLOGICAL SCIENCES, 2013, 135 (01) : 91 - 102
  • [49] Mechanisms of White Matter Damage in Multiple Sclerosis
    Lassmann, Hans
    GLIA, 2014, 62 (11) : 1816 - 1830
  • [50] Mechanisms Underlying the Process of Demyelination in Multiple Sclerosis
    Pivneva, T. A.
    NEUROPHYSIOLOGY, 2009, 41 (05) : 365 - 373